Haemonetics | 8-K: Haemonetics Reports Fourth Quarter and Fiscal 2023 Results; Provides Fiscal 2024 Guidance
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
14:30
The Nikkei 225 Index closed down 1.05% at 39,190.40 points.
Nikkei 225-0.91%
14:30
Morgan Stanley: Rated TRAVELSKY TECH as "in line with the market" and reduced the Target Price to HKD 8.8.
MS+0.77%
14:29
China Biologics: Class I innovative antibody-drug conjugate SIBP-A18 has been approved for clinical use.